These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 27000794)

  • 1. Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.
    Chen Z; Kim J
    BMC Urol; 2016 Mar; 16():11. PubMed ID: 27000794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in urinary biomarker discovery in urological research.
    Kim J; Kim WT; Kim WJ
    Investig Clin Urol; 2020 Feb; 61(Suppl 1):S8-S22. PubMed ID: 32055750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary exosomes and proteomics.
    Moon PG; You S; Lee JE; Hwang D; Baek MC
    Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in Transplantation--Proteomics and Metabolomics.
    Christians U; Klawitter J; Klawitter J
    Ther Drug Monit; 2016 Apr; 38 Suppl 1(Suppl 1):S70-4. PubMed ID: 26418702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary proteomics and metabolomics in the diagnosis of pediatric disorders.
    Vaidyanathan K
    Proteomics Clin Appl; 2015 Jun; 9(5-6):482-9. PubMed ID: 25631340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological conditions can be reflected in human urine proteome and metabolome.
    Wu J; Gao Y
    Expert Rev Proteomics; 2015; 12(6):623-36. PubMed ID: 26472227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry.
    Nizioł J; Ossoliński K; Płaza-Altamer A; Kołodziej A; Ossolińska A; Ossoliński T; Nieczaj A; Ruman T
    Sci Rep; 2023 Jun; 13(1):9802. PubMed ID: 37328580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
    J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry based proteomics in urine biomarker discovery.
    Theodorescu D; Mischak H
    World J Urol; 2007 Oct; 25(5):435-43. PubMed ID: 17703310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine metabolomics.
    Zhang A; Sun H; Wu X; Wang X
    Clin Chim Acta; 2012 Dec; 414():65-9. PubMed ID: 22971357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine.
    Lee J; McKinney KQ; Pavlopoulos AJ; Niu M; Kang JW; Oh JW; Kim KP; Hwang S
    Mol Cells; 2018 Mar; 41(3):179-187. PubMed ID: 29562735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
    Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
    Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses.
    Thévenot EA; Roux A; Xu Y; Ezan E; Junot C
    J Proteome Res; 2015 Aug; 14(8):3322-35. PubMed ID: 26088811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine as a source for clinical proteome analysis: from discovery to clinical application.
    Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
    Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Biomarkers of Brain Diseases.
    An M; Gao Y
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):345-54. PubMed ID: 26751805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics for Renal and Urinary Proteomics: Call for Aggrandization.
    Paul P; Antonydhason V; Gopal J; Haga SW; Hasan N; Oh JW
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
    Pieragostino D; D'Alessandro M; di Ioia M; Di Ilio C; Sacchetta P; Del Boccio P
    Proteomics Clin Appl; 2015 Feb; 9(1-2):169-86. PubMed ID: 25488355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis.
    Emwas AH; Roy R; McKay RT; Ryan D; Brennan L; Tenori L; Luchinat C; Gao X; Zeri AC; Gowda GA; Raftery D; Steinbeck C; Salek RM; Wishart DS
    J Proteome Res; 2016 Feb; 15(2):360-73. PubMed ID: 26745651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
    Zhang H; Fan Y; Xia L; Gao C; Tong X; Wang H; Sun L; Ji T; Jin M; Gu B; Fan B
    Tumour Biol; 2017 Mar; 39(3):1010428317691183. PubMed ID: 28345451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.